- Emmaus Life Sciences press release (OTC:EMMA): Q2 GAAP EPS of -$0.02.
- Revenue of $2.82M (-47.6% Y/Y).
Emmaus Life Sciences GAAP EPS of -$0.02, revenue of $2.82M
1 hour ago
1
Related
Globant slides as Q3 forecast comes in below expectations
7 minutes ago
0
Gold slides as stronger than expected U.S. inflation data hi...
8 minutes ago
0
Eli Lilly partners with AI healthtech Superluminal Medicines...
8 minutes ago
0
Starboard takes new position in TripAdvisor, adds Salesforce...
9 minutes ago
0
Activist hedge fund ValueAct lowers stakes in Meta, Disney i...
9 minutes ago
0
Sandisk Corporation Non-GAAP EPS of $0.29 beats by $0.26, re...
10 minutes ago
0
Hims & Hers Health under investigation by FTC over business ...
10 minutes ago
0
Pyxis Oncology GAAP EPS of -$0.30 beats by $0.05, revenue of...
14 minutes ago
0
MFA Financial files shelf registration for multiple securiti...
14 minutes ago
0
Elliott Management takes new stake in Hewlett Packard, exits...
18 minutes ago
0
TILT Holdings reports Q2 results
18 minutes ago
0
Earnings Snapshot: Nu Holdings beats Q2 revenue estimates
18 minutes ago
0
Allied Esports Entertainment GAAP EPS of -$0.11, revenue of ...
21 minutes ago
0
Reviva Pharmaceuticals GAAP EPS of -$0.12 in-line
23 minutes ago
0
Tudor Investment takes new stakes in Copart, Alphabet C shar...
23 minutes ago
0
Milestone Scientific GAAP EPS of -$0.02 misses by $0.01, rev...
24 minutes ago
0
Nelson Peltz's Trian Fund boosts Wendy's, cuts Invesco in Q2...
27 minutes ago
0
Nu Holdings reports Q2 results
29 minutes ago
0
Minerva Neurosciences GAAP EPS of -$0.43
29 minutes ago
0
Seritage GAAP EPS of -$0.53, revenue of $4.65M
29 minutes ago
0
Popular
عکس پربازدید از فرزند تازه متولد شده پیمانقاسمخانی
2 days ago
5
عکس | ماه کامل بر فراز حرم امام حسین (ع)
5 days ago
5
English (US) · © FBT Company 2025. All rights are reserved